Implant Tribune U.S. No. 7, 2011
JOI: Gene combination identified as risk factor in success of dental implants / ICOI returns to Chicago / Clinical and diagnostic advantages of PreXion 3-D imaging system / Industry
Table of contents
Array
(
[post_data] => WP_Post Object
(
[ID] => 55657
[post_author] => 0
[post_date] => 2011-07-14 15:38:43
[post_date_gmt] => 2011-07-14 15:38:43
[post_content] =>
[post_title] => Implant Tribune U.S. No. 7, 2011
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => implant-tribune-u-s-no-7-2011-0711
[to_ping] =>
[pinged] =>
[post_modified] => 2024-10-21 18:55:55
[post_modified_gmt] => 2024-10-21 18:55:55
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://e.dental-tribune.com/epaper/itus0711/
[menu_order] => 0
[post_type] => epaper
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[id] => 55657
[id_hash] => 84ce208e43806fe2327b5c312c160fe263375f7a2d855b7b9f46e28bf27108f8
[post_type] => epaper
[post_date] => 2011-07-14 15:38:43
[fields] => Array
(
[pdf] => Array
(
[ID] => 55658
[id] => 55658
[title] => ITUS0711.pdf
[filename] => ITUS0711.pdf
[filesize] => 0
[url] => https://e.dental-tribune.com/wp-content/uploads/ITUS0711.pdf
[link] => https://e.dental-tribune.com/epaper/implant-tribune-u-s-no-7-2011-0711/itus0711-pdf-2/
[alt] =>
[author] => 0
[description] =>
[caption] =>
[name] => itus0711-pdf-2
[status] => inherit
[uploaded_to] => 55657
[date] => 2024-10-21 18:55:49
[modified] => 2024-10-21 18:55:49
[menu_order] => 0
[mime_type] => application/pdf
[type] => application
[subtype] => pdf
[icon] => https://e.dental-tribune.com/wp-includes/images/media/document.png
)
[cf_issue_name] => Implant Tribune U.S. No. 7, 2011
[contents] => Array
(
[0] => Array
(
[from] => 01
[to] => 01
[title] => JOI: Gene combination identified as risk factor in success of dental implants
[description] => JOI: Gene combination identified as risk factor in success of dental implants
)
[1] => Array
(
[from] => 01
[to] => 02
[title] => ICOI returns to Chicago
[description] => ICOI returns to Chicago
)
[2] => Array
(
[from] => 01
[to] => 07
[title] => Clinical and diagnostic advantages of PreXion 3-D imaging system
[description] => Clinical and diagnostic advantages of PreXion 3-D imaging system
)
[3] => Array
(
[from] => 11
[to] => 14
[title] => Industry
[description] => Industry
)
)
)
[permalink] => https://e.dental-tribune.com/epaper/implant-tribune-u-s-no-7-2011-0711/
[post_title] => Implant Tribune U.S. No. 7, 2011
[client] =>
[client_slug] =>
[pages_generated] =>
[pages] => Array
(
[1] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/55657-ff41a6f5/2000/page-0.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/55657-ff41a6f5/1000/page-0.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/55657-ff41a6f5/200/page-0.jpg
)
[key] => Array
(
[2000] => 55657-ff41a6f5/2000/page-0.jpg
[1000] => 55657-ff41a6f5/1000/page-0.jpg
[200] => 55657-ff41a6f5/200/page-0.jpg
)
[ads] => Array
(
)
[html_content] =>
)
[2] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/55657-ff41a6f5/2000/page-1.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/55657-ff41a6f5/1000/page-1.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/55657-ff41a6f5/200/page-1.jpg
)
[key] => Array
(
[2000] => 55657-ff41a6f5/2000/page-1.jpg
[1000] => 55657-ff41a6f5/1000/page-1.jpg
[200] => 55657-ff41a6f5/200/page-1.jpg
)
[ads] => Array
(
)
[html_content] =>
)
[3] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/55657-ff41a6f5/2000/page-2.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/55657-ff41a6f5/1000/page-2.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/55657-ff41a6f5/200/page-2.jpg
)
[key] => Array
(
[2000] => 55657-ff41a6f5/2000/page-2.jpg
[1000] => 55657-ff41a6f5/1000/page-2.jpg
[200] => 55657-ff41a6f5/200/page-2.jpg
)
[ads] => Array
(
)
[html_content] =>
)
[4] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/55657-ff41a6f5/2000/page-3.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/55657-ff41a6f5/1000/page-3.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/55657-ff41a6f5/200/page-3.jpg
)
[key] => Array
(
[2000] => 55657-ff41a6f5/2000/page-3.jpg
[1000] => 55657-ff41a6f5/1000/page-3.jpg
[200] => 55657-ff41a6f5/200/page-3.jpg
)
[ads] => Array
(
)
[html_content] =>
)
[5] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/55657-ff41a6f5/2000/page-4.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/55657-ff41a6f5/1000/page-4.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/55657-ff41a6f5/200/page-4.jpg
)
[key] => Array
(
[2000] => 55657-ff41a6f5/2000/page-4.jpg
[1000] => 55657-ff41a6f5/1000/page-4.jpg
[200] => 55657-ff41a6f5/200/page-4.jpg
)
[ads] => Array
(
)
[html_content] =>
)
[6] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/55657-ff41a6f5/2000/page-5.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/55657-ff41a6f5/1000/page-5.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/55657-ff41a6f5/200/page-5.jpg
)
[key] => Array
(
[2000] => 55657-ff41a6f5/2000/page-5.jpg
[1000] => 55657-ff41a6f5/1000/page-5.jpg
[200] => 55657-ff41a6f5/200/page-5.jpg
)
[ads] => Array
(
[0] => Array
(
[post_data] => WP_Post Object
(
[ID] => 55659
[post_author] => 0
[post_date] => 2024-10-21 18:55:49
[post_date_gmt] => 2024-10-21 18:55:49
[post_content] =>
[post_title] => epaper-55657-page-6-ad-55659
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => epaper-55657-page-6-ad-55659
[to_ping] =>
[pinged] =>
[post_modified] => 2024-10-21 18:55:49
[post_modified_gmt] => 2024-10-21 18:55:49
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://e.dental-tribune.com/ad/epaper-55657-page-6-ad/
[menu_order] => 0
[post_type] => ad
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[id] => 55659
[id_hash] => 38db1520dc8d17a53c3289238973e19cacbfd732ba79a86e7bc9f919172d3507
[post_type] => ad
[post_date] => 2024-10-21 18:55:49
[fields] => Array
(
[url] => http://www.dental-tribune.com/companies/content/id/2324/code/prexion_inc_usa
[link] => URL
)
[permalink] => https://e.dental-tribune.com/ad/epaper-55657-page-6-ad-55659/
[post_title] => epaper-55657-page-6-ad-55659
[post_status] => publish
[position] => 0.06,-0.27,94.47,100.27
[belongs_to_epaper] => 55657
[page] => 6
[cached] => false
)
)
[html_content] =>
)
[7] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/55657-ff41a6f5/2000/page-6.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/55657-ff41a6f5/1000/page-6.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/55657-ff41a6f5/200/page-6.jpg
)
[key] => Array
(
[2000] => 55657-ff41a6f5/2000/page-6.jpg
[1000] => 55657-ff41a6f5/1000/page-6.jpg
[200] => 55657-ff41a6f5/200/page-6.jpg
)
[ads] => Array
(
)
[html_content] =>
)
[8] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/55657-ff41a6f5/2000/page-7.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/55657-ff41a6f5/1000/page-7.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/55657-ff41a6f5/200/page-7.jpg
)
[key] => Array
(
[2000] => 55657-ff41a6f5/2000/page-7.jpg
[1000] => 55657-ff41a6f5/1000/page-7.jpg
[200] => 55657-ff41a6f5/200/page-7.jpg
)
[ads] => Array
(
)
[html_content] =>
)
[9] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/55657-ff41a6f5/2000/page-8.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/55657-ff41a6f5/1000/page-8.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/55657-ff41a6f5/200/page-8.jpg
)
[key] => Array
(
[2000] => 55657-ff41a6f5/2000/page-8.jpg
[1000] => 55657-ff41a6f5/1000/page-8.jpg
[200] => 55657-ff41a6f5/200/page-8.jpg
)
[ads] => Array
(
)
[html_content] =>
)
[10] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/55657-ff41a6f5/2000/page-9.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/55657-ff41a6f5/1000/page-9.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/55657-ff41a6f5/200/page-9.jpg
)
[key] => Array
(
[2000] => 55657-ff41a6f5/2000/page-9.jpg
[1000] => 55657-ff41a6f5/1000/page-9.jpg
[200] => 55657-ff41a6f5/200/page-9.jpg
)
[ads] => Array
(
)
[html_content] =>
)
[11] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/55657-ff41a6f5/2000/page-10.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/55657-ff41a6f5/1000/page-10.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/55657-ff41a6f5/200/page-10.jpg
)
[key] => Array
(
[2000] => 55657-ff41a6f5/2000/page-10.jpg
[1000] => 55657-ff41a6f5/1000/page-10.jpg
[200] => 55657-ff41a6f5/200/page-10.jpg
)
[ads] => Array
(
)
[html_content] =>
)
[12] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/55657-ff41a6f5/2000/page-11.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/55657-ff41a6f5/1000/page-11.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/55657-ff41a6f5/200/page-11.jpg
)
[key] => Array
(
[2000] => 55657-ff41a6f5/2000/page-11.jpg
[1000] => 55657-ff41a6f5/1000/page-11.jpg
[200] => 55657-ff41a6f5/200/page-11.jpg
)
[ads] => Array
(
)
[html_content] =>
)
[13] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/55657-ff41a6f5/2000/page-12.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/55657-ff41a6f5/1000/page-12.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/55657-ff41a6f5/200/page-12.jpg
)
[key] => Array
(
[2000] => 55657-ff41a6f5/2000/page-12.jpg
[1000] => 55657-ff41a6f5/1000/page-12.jpg
[200] => 55657-ff41a6f5/200/page-12.jpg
)
[ads] => Array
(
)
[html_content] =>
)
[14] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/55657-ff41a6f5/2000/page-13.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/55657-ff41a6f5/1000/page-13.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/55657-ff41a6f5/200/page-13.jpg
)
[key] => Array
(
[2000] => 55657-ff41a6f5/2000/page-13.jpg
[1000] => 55657-ff41a6f5/1000/page-13.jpg
[200] => 55657-ff41a6f5/200/page-13.jpg
)
[ads] => Array
(
)
[html_content] =>
)
[15] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/55657-ff41a6f5/2000/page-14.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/55657-ff41a6f5/1000/page-14.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/55657-ff41a6f5/200/page-14.jpg
)
[key] => Array
(
[2000] => 55657-ff41a6f5/2000/page-14.jpg
[1000] => 55657-ff41a6f5/1000/page-14.jpg
[200] => 55657-ff41a6f5/200/page-14.jpg
)
[ads] => Array
(
)
[html_content] =>
)
[16] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/55657-ff41a6f5/2000/page-15.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/55657-ff41a6f5/1000/page-15.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/55657-ff41a6f5/200/page-15.jpg
)
[key] => Array
(
[2000] => 55657-ff41a6f5/2000/page-15.jpg
[1000] => 55657-ff41a6f5/1000/page-15.jpg
[200] => 55657-ff41a6f5/200/page-15.jpg
)
[ads] => Array
(
)
[html_content] =>
)
)
[pdf_filetime] => 1729536949
[s3_key] => 55657-ff41a6f5
[pdf] => ITUS0711.pdf
[pdf_location_url] => https://e.dental-tribune.com/tmp/dental-tribune-com/55657/ITUS0711.pdf
[pdf_location_local] => /var/www/vhosts/e.dental-tribune.com/httpdocs/tmp/dental-tribune-com/55657/ITUS0711.pdf
[should_regen_pages] => 1
[pdf_url] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/55657-ff41a6f5/epaper.pdf
[pages_text] => Array
(
[1] =>
on
ed
iti
ia
l ICOI
of
fic
IMPLANT TRIBUNE
The World’s Dental Implant Newspaper · U.S. Edition
July 2011
www.implant-tribune.com
INDUSTRY CLINICAL
Vol. 6, No. 7
ICOI returns
to Chicago
Fig. 1: Saggital CBCT MPR showing
bone defect at point of dehiscence of
the implant coating.
Clinical and
diagnostic
advantages of
PreXion 3-D
imaging system
Chicago is the site for the ICOI’s 14th annual Implant Prosthetic Summer Symposium. (Photo/Christiane Ferret,
Dental Tribune)
Windy City welcomes ICOI Implant Prosthetic Symposium in August
By Dan McEowen, DDS
By Craig Johnson, ICOI Executive Director
For nearly 100 years, dentists have
relied on 2-D radiographic imaging for
diagnosis and treatment planning. With
the 1999 introduction of cone-beam
computed tomography (CBCT), all dentists now have tools available for more
accurate diagnosis and treatment.1
The ability to look at a tooth in any
direction and orientation, as well as
in 3-D, eliminates much of the guesswork commonly experienced with
2-D radiographs.
We have been limited in most
cases to only a buccal-lingual view
provided by periapicals, bitewings
and panoramic radiographs with the
occasional axial view of an occlusal
film. Medical CT scans and images
began in the early 1970s and were
sometimes used by dentists, offering
our first multi-planer views.2
The adoption of 3-D cone-beam
imaging is appropriate and has
important advantages for all modalities of dentistry. From every specialist
to the general dentist, the increased
amount of radiographic information
as well as increased accuracy will aid
in the most sound diagnosis possible.
The International Congress of
Oral Implantologists (ICOI) will
return to one of its favorite locales
for its 14th annual Implant Prosthetic Summer Symposium. The dates to
add to your calendar are Aug. 18-20,
CBCT description
CBCT is a single or partial rotation
of an X-ray source around the head,
capturing X-rays on various flat panel
arrays and sensors. The information is
converted to a series of axial slices by
computed tomography and stored as
g IT page 2B
and the venue will be the Downtown
Marriott Hotel on Michigan Avenue
in the heart of Chicago. Just steps
from the famous Navy Pier and the
excitement of summer in the city,
this meeting promises both educational enrichment and social opportunities.
The Chicago program’s goal is
about education for everyone on
the implant team. Formulated with
the original vision of ICOI’s Implant
Prosthetic Symposium, the mission is to highlight the restorative
g IT page 2B
JOI: Gene combination identified as
risk factor in success of dental implants
The health of the surrounding
tissue affects the success of a dental
implant. Identifying and reducing
risk factors is therefore a key step in
the implant process. Now a combination of genes has been identified as
a possible indicator of greater tissue
destruction leading to negative outcomes for implants.
The authors of an article in the
Journal of Oral Implantology report
on a study of individuals with the
combination of interleukin (IL)-1
allele 2 at IL-1A−889 and IL-1B+3954.
These people are “genotype positive”
and susceptible to increased periodontal tissue destruction.
Peri-implantitis, or the process
of tissue inflammation and destruction around failing implants, is very
similar to periodontal disease. The
researchers sought to find any association of these genotypes with the
severity of peri-implantitis progression and the effect of this combina-
tion on treatment outcomes.
This study compared two groups
of patients, all of whom had implants.
The first group consisted of 25
patients with peri-implantitis, while
the second group of 25 patients had
healthy tissue. Seventeen patients
from the first group and five from the
second group were genotype positive.
Patients in the first group, those
with peri-implantitis, took part in
a treatment and maintenance program. The genotype-positive patients
in this group experienced greater
periodontal tissue destruction and
increased discharge from tissues.
The genotype-negative patients
responded better to treatment. Statistically significant differences were
noted between the groups.
The combination of these two
alleles in patients with inflamed periodontal tissues denotes a risk factor that can lead to further tissue
destruction. Patients with the specific
genotype can have exaggerated local
inflammation. Gene polymorphism
may affect the outcomes of treatment
for peri-implantitis in genotype-positive people and affect the long-term
success of implants.
Full text of the article, “The Effect
of Interleukin-1 Allele 2 Genotype (IL1a−889 and IL-1b+3954) on the Individual’s Susceptibility to Peri-Implantitis: Case-Control Study,” Journal of
Oral Implantology, Vol. 37, No. 3, 2011,
is available at http://allenpress.com/
publications/journals/orim.
About the Journal of Oral
Implantology
The Journal of Oral Implantology is
the official publication of the American Academy of Implant Dentistry
and of the American Academy of
Implant Prosthodontics. For more
information about the journal or
society, visit www.joionline.org/
orimonline/?request=index-html. IT
[2] =>
2B
Events/Industry Clinical
f IT page 1B
aspects of implant dentistry, with a
focus on expanding technologies that
enhance the daily practice for the
GP, the specialist, dental auxiliary
and dental laboratory technician.
The scientific program will begin
on Thursday afternoon, Aug. 18, with
a focus on the latest in esthetics and
prosthetic reconstruction techniques.
Friday will deal with recent innovations in guided surgery applications
and treatment of the atrophic patient
as presented from the clinician and
laboratory technician perspective.
The program will conclude on
Saturday with presentations on
occlusion, over-denture concepts,
complications and advancements in
restorative components.
Dr. Scott Ganz has arranged the
scientific program, which features
speakers including Drs. Natalie
Wong, Michael Moskovitch, Philippe
Russe, Lampert Stumpel, Thomas
Balshi, Dwayne Kareteew, Michael
Pikos, Jack Krauser, Konstantinos
Valavanis, Barry Goldenberg, Aldo
Leopardi, Carl Misch, Paul Wiegel,
Marius Steigmann, Hom-Lay Wang,
Ady Palti, Zeev Ormianer, Roberto
Marra and dental technicians Stephen Balshi, Renzo Casellini and
Ulrich Hauschild and many more.
The ICOI is an ADA CERP and
AGD PACE Recognized Provider.
This symposium is designated for 19
continuing education credits.
Preceding the general session,
there will be six pre-symposium
workshops on Thursday morning
offered by the two Gold sponsors,
Nobel Biocare and Osstell, and the
five Silver sponsors, BioHorizons,
Dentsply Tulsa Dental Specialties,
Implant Direct, Osteogenics and
PreXion. For complete information
on these courses and on the meeting
in general, visit ICOI’s web site at
Implant Tribune | July 2011
www.icoi.org.
In addition, ICOI will continue to
hold its Table Clinic/Poster Presentation competition for delegates at all
levels of experience. These will take
place Thursday evening during the
Welcome Reception in the Exhibition
Hall.
ICOI’s auxiliary section (ADIA)
will also hold a two-and-a-half-day
program (in tandem with the doctors program), which will include
its full-day certification programs
for hygienists, dental assistants and
practice management staff members.
Delegates should make sure to
contact the host hotel, the Downtown Marriott on Michigan Avenue,
as rooms are going fast.
To contact the Marriott, call (800)
266-9432, or visit www.icoi.org, and
make reservations online. But do so
today.
We want to see you this August in
that Toddelin’ Town, Chicago. IT
IMPLANT TRIBUNE
The World’s Newspaper of Implantology · U.S. Edition
Publisher & Chairman
Torsten Oemus
t.oemus@dental-tribune.com
Chief Operating Officer
Eric Seid
e.seid@dental-tribune.com
Group Editor & Designer
Robin Goodman
r.goodman@dental-tribune.com
Editor in Chief
Sascha A. Jovanovic, DDS, MS
sascha@jovanoviconline.com
Managing Editor/Designer
Implant, Endo & CAD/CAM Tribunes
Sierra Rendon
s.rendon@dental-tribune.com
Managing Editor/Designer
Ortho Tribune & Show Dailies
Kristine Colker
k.colker@dental-tribune.com
Online Editor
Fred Michmershuizen
f.michmershuizen@dental-tribune.com
Account Manager
Humberto Estrada
h.estrada@dental-tribune.com
f IT page 1B
Marketing Manager
Anna Wlodarczyk
a.wlodarczyk@dental-tribune.com
virtual anatomy in the computer.
With the use of sophisticated software, the dentist is able to view information in several different views,
including: axial slices (head-to-toe
orientation), coronal slices (frontto-back orientation), saggital slices
(side-to-side orientation) all known
as multi-planer reconstructions
(MPR). The thickness of each slice
can be varied to include more or less
information.
Because the voxels (volumetric
pixels 3-D) are isotropic, other MPR
images can be generated by slices
drawn at any angle, curve or thickness through the scan to view areas
critical to the final diagnosis.3,8
The final view offered by CBCT is
a 3-D view that can be rotated and
viewed in any direction.
Once again through software
manipulation, 3-D images can be
viewed as conventional radiographs,
maximum intensity projections
(MIP), soft-tissue projections and a
variety other views.
This nearly endless ability to
manipulate the data aids in the diagnosis and identification of disease,
nerve canals, sinus morphology, dental caries, bone density, fractures,
endodontic pathology, implant placement criteria, periodontal defects,
bone pathology, fractured teeth, iatrogenic trauma, TMJ morphology
and disease, third-molar position and
many more healthy or diseased conditions.
Marketing & Sales Assistant
Lorrie Young
l.young@dental-tribune.com
C.E. Manager
Julia Wehkamp
j.wehkamp@dental-tribune.com
International C.E. Sales Manager
Christiane Ferret
c.ferret@dtstudyclub.com
Fig. 2: Periapical does not show the
sinus anatomy or the width of the bone.
Fig. 3: MPR showing post op of
sinus graft and implant placement.
Dental Tribune America, LLC
116 W. 23rd St., Suite #500
New York, NY 10011
Phone: (212) 244-7181, Fax: (212) 244-7185
Published by
Dental Tribune America
© 2011 Dental Tribune America.
All rights reserved.
Fig. 4: The 3-D CBCT showing anatomy of the maxillary sinuses.
Early CBCT adoption with
implants
The first and primary use of CBCT for
early adopters was implant placement.
As the scope and the value of the information became better known, dentists
of all branches began to see the value
Fig. 5: Axial MPR showing mesial buccal
roots in first, second and third molars.
of MPRs and 3-D renderings including periodontics, endodontics, oral surgery, treatment of TMJ, orthodontics,
implantology and general dentistry.1,7,8
Clinical peri-apical and panoramg IT page 4B
Dental Tribune makes every effort
to report clinical information and
manufacturer’s product news accurately, but cannot assume responsibility for the validity of product
claims, or for typographical errors.
The publishers also do not assume
responsibility for product names
or claims, or statements made by
advertisers. Opinions expressed by
authors are their own and may
not reflect those of Dental Tribune
International.
Editorial Advisory Board
Dr. Sascha Jovanovic, Editor in Chief
Dr. Bernard Touati
Dr. Jack T. Krauser
Tell us
what
you
think!
Do you have general comments or criticism you
would like to share? Is there a particular topic
you would like to see more articles about? Let us
know by e-mailing us at feedback@dental-tribune.
com. If you would like to make any change to your
subscription (name, address or to opt out) please
send us an e-mail at database@dental-tribune.
com and be sure to include which publication you
are referring to. Also, please note that subscription
changes can take up to six weeks to process.
IT
Corrections
Implant Tribune strives to
maintain the utmost accuracy in its news and clinical
reports. If you find a factual
error or content that requires
clarification, please report the
details to Managing Editor
Sierra Rendon at s.rendon@
dental-tribune.com.
Dr. Andre Saadoun
Dr. Gary Henkel
Dr. Doug Deporter
Dr. Michael Norton
Dr. Ken Serota
Dr. Axel Zoellner
Dr. Glen Liddelow
Dr. Marius Steigmann
[3] =>
[4] =>
4B
Industry Clinical
Implant Tribune | July 2011
f IT page 2B
ic radiographs for the placement of
implants can be misleading with elongation, foreshortening, superimposition
and geometrically incorrect data.7,8 A
look at the implant in the periapical
shows no obvious disease to an existing
integrated implant. Clinically, a buccal
fistula was present with exudate and
slight pain. The CBCT scan (Fig. 1)
reveals a more accurate view showing
a buccal defect on a saggital MPR. A surgical flap revealed a dehiscence of the
coating of the implant. Removal of the
foreign body resulted in an asymptomatic and healthy patient
The evaluation of the available bone
for the initial implant placement can be
crucial for the long-term success of the
case. If there is inadequate bone available, grafting may be a necessity. CBCT
studies render the most accurate information available at a low radiation dose.
The periapical shows an obvious lack of
bone height, but does not show the buccal-lingual dimensions or an accurate
view of the sinus morphology (Fig. 2).
The MPR view of the CBCT shows
all necessary measurements to perform the sinus lift and grafting with the
immediate placement of the implant
fixture (Fig. 3). 3-D views show the
floor of the sinus and any soft-tissue
pathology (Fig. 4). Having accurate
measurements in all dimensions is an
advantage of CBCT scanning.
AD
Fig. 6: Periapical showing minimal
pathology with no radiolucency.
CBCT and endodontics
Endodontics is a field that is rapidly
adopting the use of CBCT and for
good reason. The inherent geometric
deficiencies of 2-D radiographs make
the CBCT scan a valuable adjunct to
investigate the root morphology in both
3-D and MPR. The typical periapical
will show superimposed canals in the
anteriors, bicuspids and molars as well
as unwanted bone densities both buccal and lingual to the affected tooth
making the image quality poor.
The ability to view MPR slices in
cross-section, long axis and oblique
directions gives the ability to follow all
canals in any direction and show their
relationship and measurements from
other known structures. This virtual tour
of the root morphology is a great benefit
to the final treatment outcome (Fig. 5).3,4
Post root-canal infection can be difficult to diagnose with the standard peri-
Fig. 7: Coronal MPR showing a
short fill on the mesial lingual and
radiolucency.
Fig. 8: Saggital MPR showing
unfilled canal and radiolucency.
Fig. 9: Periapical showing a normal
fill with a radiolucency.
apical. The endodontic fills may appear
to be normal even though other clinical
findings and symptoms are abnormal.
The patient presents several months post
root-canal treatment with pain on palpation and pressure and avoids this side
of the mouth. A periapical radiogragh
shows minimal pathology (Fig. 6). The
roots appear to be filled and a small puff
of sealer extends through the apex of the
mesial roots. The distal root structure
and fill appear normal. There is little
indication of periapical radiolucency
only a widening of the periodontal ligaments of the mesial roots.
A CBCT scan reveals a completely
different picture. The coronal MPR
reveals a short fill near the apex of the
mesial lingual root and a large radiolucency (Figs. 7, 8) not visible on the
periapical radiograph (Fig. 6).
Missed canals are difficult to see
in a buccal-lingual projection of the
periapical radiograph as on canal is
superimposed on the other (Fig. 9).
Often, as viewed in this radiograph,
we see periapical pathology with an
apparent normally filled canal. CBCT
scans allow dentists to look for pathology in MPR planes to identify the actual
problem before invasive procedures
are performed on the patient. The axial
view shows a lingual canal exists and
is untreated. The coronal view confirms the diagnosis and treatment can
be completed (Fig. 10).
Today’s endodontists, as well as
general dentists, are benefiting from
the diagnostic capabilities of the highresolution CBCT scanners available
over conventional 2-D periapical.5,6
Oral surgery
Oral surgery, with its inherent invasive nature, can be better served using
CBCT with MPR as well as 3-D images.
The ability to perform virtual surgery
is a benefit to both the doctor and the
patient. Doctors have the advantage of
seeing morphology and landmarks in
real time and space with accurate measurements, and patients will gain a bet-
Fig. 10: Coronal MPR showing the
superimposed lingual root unfilled.
Fig. 11: Coronal MPR showing nerve
between roots of the third molar.
Fig. 12: The 3-D rendering showing
supernumary teeth and positions.
ter understanding of the problems and
the solutions their doctors are offering
them.
Third-molar extractions can be risky
based on 2-D and panoramic radiographs. These radiographs can often
superimpose nerves and sinuses over
root structures. Dentists using 2-D radiographs must often rely on experience
to assess the risks of iatrogenic trauma.
The use of CBCT with MPRs and 3-D
images reduces any guessing as well
as the chance for any permanent damage to the patient. With the adoption of
CBCT, the judgment is based on solid
[5] =>
Implant Tribune | January 2011
IT
Digital Imaging 5B
[6] =>
6B
Clinical
Implant Tribune | December 2010
Visit PREXION at the ICOI Summer
Implant Prosthetic Symposium
Booths 403 & 405
[7] =>
Implant Tribune | July 2011
f IT page 4B
evidence and the risk will decrease.
A panorex of the superimosed third
molars gave no solid evidence the
canal lies between the roots. It is only
with the use of CBCT and the MPRs
that the nerve can accurately be seen
traversing between the mesial buccal
and mesial lingual root (Fig. 11).4,5
Other surgical advantages include
the identification and the position of
supernumerary or impacted teeth.
The images show accurate positions
and show definitive morphology that
will aid in removal of the proper teeth
(Fig. 12). Knowing the exact position
of many of these teeth is a benefit to
both the doctor and patient. It will
lead to the most precise surgical path
and the least invasive procedure.
Periodontics
The explanation of periodontal problems
are often misunderstood by the patient.
As doctors we talk about pockets, point
to X-rays and propose treatment only to
have patients refuse treatment because
they do not understand what we are
clinically describing. Using the 3-D portion of the CBCT scan can improve the
understanding and acceptance of treatment plans. The images are a picture
of the problem that is owned by that
patient and much easier to understand
by the layperson. Illustrating periodontal
defects and pockets allows the patient to
better participate in the process (Fig. 13).
The MPRs and the 3-D projections aid
in surgical planning for periodontists,
allowing for accurate measurements
and bone analysis prior to osseous surgery that doctors can not get using the
periapicals or panoramics. Studies have
shown that CBCT images are more
accurate than panoramic radiographs.
For the periodontist placing implants,
the ability to measure bone density and
avoid important anatomy is important.4,5
Orthodontics
Orthodontists are beginning to adopt
large field-of-view CBCT. Recent studies show that linear measurements
of bony structures are more accurate
using CBCT and have less distortion
than currently used methods of measurement: lateral cephalometric, posteroanterior (PA) and submentovertex
(SMVT).5 Accurate measurements of
tooth volume and tooth position can
aid in accelerated treatment times and
more precise treatment.
Along with tooth position, density of
bone and size of arches, the orthodontist also has an accurate evaluation of
the temporomandibular joint and position of the condyles. Impacted teeth
are easily identified and position either
buccal or lingual can be confirmed
prior to movement or removal. Both
MPRs and 3-D projections give the doctor a complete picture of the problems
and the treatment course. With a single
CBCT scan, the orthodontist can produce all of the information they need:
panoramic, cephalametric, PA, SMVT,
tooth size and volume, crowding evaluation in any plane, TMJ evaluation
and airway analysis, all with both softtissue and skeletal information.5,7
Conclusion
We treat our patients in 3-D, and now,
Fig. 13: The 3-D Rendering with periodontal defects and calculus bridge.
with cone-beam computed tomography, we are changing the way we
diagnose from 2-D to 3-D. The addition
of this technology will increase your
diagnostic skills with better and more
complete information at your disposal.
As with any type of invasive diagnostic
Industry Clinical 7B
tool, doctors should weigh the risk to
benefit in using CBCT scans.
Judicious use of CBCT and knowledge of patient’s lifetime doses should
always be a consideration as well
as the availability of other diagnostic
tests appropriate for the problems of
the patient. When adopting new technology, training is paramount. Along
with training comes the responsibility of the doctor to read and diagnose
information from CBCT scans.
Do not avoid CBCT from lack of
knowledge; instead, take this opportunity to become a better diagnostician
and radiologist. As you review radiology and pathology, your use of CBCT
will aid in making the most accurate diagnosis and the most complete
treatment plans. IT
References available upon request
from the publisher.
IT
About the author
Dr. Dan McEowen is a 1982 graduate of Loma Linda School of Dentistry
and has been in private practice for 26
years. He is a founding member of the
World Clinical Laser
Institute, achieving
a mastership level of
proficiency. He has
been active in FDA approval of oral surgery techniques using Erbium lasers.
McEowen has lectured and trained
internationally in techniques using
lasers in general and specialty dental
fields. He a member of the ICOI and is
active in implantology. McEowen has
been involved in cone-beam technology for more than five years and owns
3D Imaging Center in Maryland.
AD
[8] =>
00
Folio
Implant Tribune | September 2009
[9] =>
[10] =>
10B
Industry
Implant Tribune | March 2011
IT
[11] =>
Industry 11B
Implant Tribune | July 2011
MIS Implants hosts global meeting
MIS Implants Technologies Inc.
continues to offer its existing and new
clients valuable products and service.
For close to eight years, the company
has established itself
in the United States
as a leader in the
implant community.
Not only does it offer
exceptional implants,
the company asserts,
but it is also known
for having exceptional customer service
and innovative surgical products.
Recently, its parent company, MIS
Implants Technologies Ltd., held its first global meeting
in Cancun, Mexico, with more than 25
international speakers. Also, handson courses were offered at the event
by two continuing education companies. About 800 doctors attended the
global conference.
“The response by our clients and
clients around the world exceeded
our expectations,” said Motti Weisman, CEO of MIS Implants Technologies Inc.
One of the systems offered by MIS
certainly is responsible for some of
the popularity MIS is experiencing,
MIS factory in Israel. (Photos/Provided by MIS Implants Technologies)
the company says. The Seven system
from MIS Implants creates a simple
solution for dentists with all levels
of experience in implantology. These
self-tapping implants are available in
diameters ranging from 3.3 to 6.0 mm
and in varying lengths from 6* mm
to 16 mm with an internal hex connection.
Micropores and macropores on the
surface of the implant, created by
particle blasting and acid etch treatment, allow for excellent osseointegration. Each of the implants is packaged with a sterile final drill made to
the specifications for the length and
diameter of each implant, ensuring
a sharp and clean drill for each surgery along with an ideally sized osteotomy. The implants’ thread thickness changes along the length of the
implant, which compresses the bone
as the implant is inserted, maximizing
initial stability. These features combine to produce an implant ideally
suited for immediate or accelerated
loading.
While the Seven implants have
a full range of prosthetic options, a
popular product is the CPK (Complete
Prosthetic Kit) which includes everything a restorative dentist needs for a
simple single implant restoration and
is available in varying abutment and
collar heights.
Other prosthetic options include
gold and plastic custom abutments,
Zest Locators, ball attachments, multiunit two-piece abutments, temporary
plastic cylinders and a wide range of
prefabricated titanium abutments.
In addition to implants and superstructures, MIS also offers its clients bone-augmentation materials.
4-Bone is a fully synthetic bone substitute made of HA and TCP. Its microand macroporosity promotes invasion
of osteogenic cells as well as allowing biological fluid diffusion. More
recently, MIS started to market BondBone. This product is a unique biphasic calcium sulfate material which
can be used on its own or combined
with other granular bone substitute
products to form a cementable composite graft.
IT
Here at ICOI
For more information, MIS Implants
Technologies, Inc., can be reached
by calling (866) 797-1333, online at
www.misimplants.com or stop by the
company’s ICOI booth Nos. 206/208
For restorative doctors, MIS’ Prosthetic Planning Kit is a helpful addition. Duplicates of the superstructures
are presented and color-coded to differentiate between the standard and
wide platforms.
The MIS factory in Israel is a stateof-the art facility. Quality control is
ensured by visual and laser inspection with the products meeting stringent international standards. MIS’
world-class scientists and engineers
are committed to continuous research
and development of new and progressive products and technologies for the
global dental implantation field.
Laboratory and clinical studies in
the areas of tissue culture and tissue engineering are jointly conducted
with prestigious universities and scientific research institutes. IT
* Available August 2011
(Source: MIS Implants Technologies)
AD
[12] =>
12B Industry
Implant Tribune | July 2011
ChaseHealthAdvance offers options
ChaseHealthAdvance
provides
patient financing for dental and orthodontic treatment.
We
help patients
overcome
the financial
barriers associated with
elective procedures not
covered
by
insurance by
(Photo/Provided by
providing no ChaseHealthAdvance)
interest
and
extended payment financing.
We are driven by two core values
— creating innovative products and
advocating for the patient and the
practice. These values can be seen in
our “No Surprise” financing, written
with simple, easy-to-understand product terms and disclosures. Our goal
is to make sure that nothing catches
a patient or practice off-guard during
the financing process.
Committed to practitioners
Enrolling in ChaseHealthAdvance is
easy and quick. There are no enrollment fees, monthly minimums or
required equipment to buy or lease.
Every practice gets a knowledgeable
AD
IT
Here at ICOI
Visit booth No. 307 at the ICOI Symposium to take advantage of special
signup promotions. For additional information, call us at (888) 388-7633 or visit
AdvanceWithChase.com.
practice consultant who trains doctors
and their staff and continues to work
with the practice throughout the life of
the relationship.
Our providers can also visit Health
Advance-Online to download free
resource guides written by top professionals in the dental industry. These
guides were printed as a courtesy of
ChaseHealthAdvance and cover topics
pertinent to implant dentistry, such as
treatment innovations, practice management and marketing.
ChaseHealthAdvance is a great
option for practices that haven’t offered
third-party financing in the past and
those currently providing financing
in-house. While some implant dentists
may believe paying a service fee for
financing is an unnecessary expense,
they fail to consider that not offering
third-party financing may actually be
costing them money.
Our providers pay a small service
fee that gives them the opportunity
to offer no-interest financing to their
patients. Even with these service fees,
our financing can greatly reduce a
practice’s costs and help increase
profitability. With in-house financing,
for instance, dental practices spend a
significant portion of their budget on
financing administration and implementation costs.
Plus, unless a patient has paid in
full, dentists must often “float” the
costs of treatment until payment can
be made — an average of 72 days.
ChaseHealthAdvance directly deposits the treatment fee into the practice’s account in as little as 24 hours
after the transaction, which can help
improve cash flow in the practice
With ChaseHealthAdvance, patients
are accountable to us and not the clinician for payments. This means dental
implant offices can stop spending valuable time and resources on financing administration and collection, and
focus on providing the best care possible for patients. And, because patients
are responsible to us for repayment and
not the practice, patients will be less
likely to skip or delay follow-up treatments because of an inability to pay.
Committed to patients
ChaseHealthAdvance has done everything possible to make it fast and easy
for patients to apply for financing.
Whether patients are applying on their
own or through the dentist’s office,
our streamlined process speeds up the
application process and helps patients
say “Yes” to getting the care they need.
And with our clear and simple language, patients will never be surprised
by an unexpected payment.
The credit application can be completed right in the doctor’s office or
at home, on the phone or online.
The approval process is automated,
so in most cases patients know their
approval status, financeable amount
and repayment options within just a
couple of minutes.
We’ve also developed a Present
and Apply tool for the iPad®, which
allows practitioners to walk patients
through the case presentation process
in a visual format that communicates
affordability and helps remove the
cost barrier for the patient.
The ChaseHealthAdvance
difference
ChaseHealthAdvance uses a custom
credit score formulation to determine
credit eligibility. We never require a
down payment, and up to 100 percent
of the treatment costs can be financed.
Once approved, patients can
choose from a broad range of “No Surprise” financing plans. For the dental
implant market, patients can choose
a no-interest repayment plan of 12,
18 or 24 months, as well as extended
plans as long as 48 months. Patients
will know what to expect from the
first payment to the last. Every loan
we approve has a generous minimum
credit line, allowing patients to fully
fund the entire cost of treatment. Dental implant patients can qualify for
extended credit up to $20,000.
ChaseHealthAdvance also lets
patients reuse credit lines for themselves or anyone in the family. IT
(Source: ChaseHealthAdvance)
Osteogenics Biomedical offers free
implant site development booklet
Osteogenics
Biomedical,
through its educational division,
Osteogenics Clinical Education™, is
currently offering
its “Implant Site
Development and
Extraction Site Grafting” booklet free
to clinicians.
The 43-page booklet covers topics
such as bone biology and physiology,
selection of grafting materials, selection of barrier membranes, surgical
techniques and patient-management
considerations. The booklet also contains illustrations, product scanning
electron micrographs, histological references, terminology definitions, case
reports, abstracts of published papers,
a treatment decision tree for various
grafting scenarios and a step-by-step
guide to the Cytoplast Technique™ for
extraction site grafting.
“The implant site development
booklet is a great resource for implant
dentists, and many also find that it’s a
great resource for their referring dentists,” said company President Shane
IT
Here at ICOI
Visit booth No. 202 at the ICOI Symposium to learn more about Osteogenics
Biomedical.
Shuttlesworth. “The comprehensive
section on the use and selection of
grafting materials is a unique resource
that most dentists find very useful.”
Osteogenics Clinical Education,
provider of this booklet and other
clinical resources, was established
in 2008 with a mission of providing clinical literature and interactive,
hands-on education in bone grafting
and implant dentistry. The “Implant
Site Development and Extraction Site
Grafting” booklet, as well as other
clinical literature and surgical videos, are available on the Osteogenics
website.
To download an electronic version
of the booklet, visit www.osteogenics.
com/clinical_literature. To request a
free hard copy of the booklet for your
library, call (888) 796-1923. IT
(Source: Osteogenics Biomedical)
[13] =>
Implant Tribune | July 2011
Industry Clinical 13B
[14] =>
14B Industry
Implant Tribune | July 2011
AstraZeneca to sell Astra Tech
to DENTSPLY International
AstraZeneca announced on June 22
that it has agreed to sell its Astra Tech
business to DENTSPLY International
for approximately $1.8 billion in cash.
Astra Tech, headquartered in
Mölndal, Sweden, has two main business divisions: a dental division, which
is engaged in the research, development, manufacturing and marketing
of dental implants, and a healthcare
division, a business focused on medical devices for use primarily in urology
and surgery.
In 2010, Astra Tech recorded worldwide revenue of $535 million and normalized EBITDA of $105 million, with
net assets valued at approximately $0.3
billion at May 2011 rates of exchange.
The transaction is anticipated to
be completed during the second half
of 2011, subject to receipt of relevant
regulatory clearances. Upon closing, a
gain will be recorded as “other operating income” in the AstraZeneca profit
and loss account. The gain will be
considered a “significant item” to be
excluded from core financial mea-
IT
Here at ICOI
Visit booth No. 308 at the ICOI Symposium to learn more about Astra Tech’s
implant products and services.
sures. As a result, there will be no
impact on the company’s full year 2011
guidance for core earnings per share.
CEO David Brennan of AstraZeneca said: “Following a comprehensive strategic review, we believe this
transaction represents an excellent
outcome for AstraZeneca shareholders. The high degree of interest and
the competitive nature of this process is evidence of the value that the
employees of Astra Tech have built in
the marketplace. I want to thank them
for their contribution and believe they
are well placed to build upon this successful foundation under DENTSPLY’s
ownership.”
About Astra Tech
Astra Tech AB, a company in the Astra-
Zeneca group, is a global leader in dental and healthcare (urological and surgical) products, services and support.
An innovation-driven company since
its foundation in 1948, Astra Tech has
continually developed market-leading
solutions to meet healthcare needs
based on user and medical community
input. Ongoing research and development is aimed at finding new ways to
support caregivers and improve quality of life for patients worldwide.
Astra Tech headquarters are located in Mölndal, Sweden, with production facilities in Sweden and North
America. The company is represented
globally with marketing subsidiary
presence in 21 countries and selected
local distribution partners. Astra Tech
has 2,200 employees worldwide.
About DENTSPLY
DENTSPLY designs, develops, manufactures and markets a broad range of
professional dental products including dental implants, endodontic
instruments and materials, orthodon-
tic appliances, restorative materials,
preventive materials and devices, and
prosthetic materials and devices. The
company distributes its professional
dental products in more than 120
countriess. DENTSPLY is committed to the development of innovative, high quality, cost-effective new
products for the professional dental
market.
About AstraZeneca
AstraZeneca is a global, innovationdriven biopharmaceutical business
with a primary focus on the discovery, development and commercialization of prescription medicines for
gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease.
AstraZeneca operates in more than
100 countries and its innovative medicines are used by millions of patients
worldwide. For more information,
visit www.astrazeneca.com. IT
(Source: Astra Tech)
DMX Implants, subsidiary of Dentatus USA,
announces formation of education team
DMX Implants is committed to
hands-on training, and along with
the Dentatus CDE Studies Institute,
providing dental health professionals
with quality, up-to-date continuing
education to further their knowledge,
skills and ability to offer comprehensive treatment to their patients.
The CDE Studies Institute courses
are PACE-accredited by the Academy
of General Dentistry. The recent formation of their education team offers
dentists and their teams education
opportunities throughout the United
States.
The team includes:
• Dr. Robert M. D’Orazio, DDS,
FAGD, MIIF, ABOI/ID, is a 1984 graduate of the University of Detroit,
School of Dentistry. In 1987, he
obtained a fellowship in the Academy of General Dentistry. In 1991,
D’Orazio completed a two-year
externship at the Midwest Implant
Institute, which included obtaining
an ACLS certificate and intravenous
conscious sedation training. He is
a past president and board member of the Midwest Implant Institute Fellowship. D’Orazio is a fellow of the American Academy of
Implant Dentistry. In 1999, he was
program chairman for the American Academy of Implant Dentistry’s
annual international meeting. He is
a diplomate of the American Board
of Oral Implantology. D’Orazio has
From left,
Dr. Chuck
Schlesinger, Dr.
Mark Iacobelli,
DMX Implants
President Nita
Weissman, Dr.
Rob D’Orazio
and Dr. Keith
Rossein.
(Photo/
Provided by
DMX Implants)
taught and lectured on the subject of
implant dentistry in Canada, Mexico
and the United States. He currently
maintains a referral-based implant
dental practice located in Sterling
Heights, Mich. He, his wife Linda,
and their son, PJ, reside in Lake
Orion, Mich.
• Dr. Mark A. Iacobelli, DDS,
FAGD, FICD, graduated from Case
Western University School of Dentistry in 1982. Since then he has
completed postgraduate programs
in orthodontics, neuromuscular and
TMD treatments for jaw and head
pain, esthetic and cosmetic dentistry,
implant placement and restoration,
and a one-year program on conscious sedation with Advanced Cardiac Life Support. He has been in
private practice since June 1982 and
holds licenses and sedation permits
in the states of Ohio and Florida.
Iacobelli is a fellow of the Academy
of General Dentistry, the Midwest
Implant Institute, and the International College of Dentists and is a
member of many dental organizations. Iacobelli is teaching and presenting for the Center for Occlusal
Studies, The Midwest Implant Institute Fellows Symposium and Outreach Programs, Jamison Consulting
of Florida, the Midwest Implant Institute and the Camlog Corporation.
Iacobelli attains balance in his life by
being the best husband, father and
little league baseball coach that he
can be.
• Dr. Keith Rossein, a consultant,
author and lecturer, has a unique
combination of clinical, marketing
and manufacturing dental experience. He received a DDS from New
York University College of Dentistry
in 1970 and went on to 23 years of
clinical practice. He is president of
International Dental Consultants, the
editor of Implant News & Views, is
formerly an instructor at NYU College of Dentistry, attending dentist at
Triboro Hospital at Queens Hospital
Center and has appeared on the program of national and international
dental meetings. He is published
in many dental journals, including
Compendium, Dental Economics,
Contemporary Esthetics and Quintessence International. Rossein is listed
in the Seattle Study Club’s Speakers
Bureau and has been a speaker for
the ADA Seminar Services.
• Dr. Charles Schlesinger, FICOI,
graduated from the Ohio State University College of Dentistry in 1996.
Following graduation, he completed
a GPR with the VAMC San Diego and
went on to become chief resident of
the GPR program at the VAMC W.
Los Angeles. During his time in LA,
he received extensive training in oral
surgery, implantology and complex
restorative dentistry. Schlesinger lectures nationally on implantology and
currently maintains a private practice
in San Diego that focuses on cosmetic
and implant dentistry. IT
(Source: DMX Implants)
[15] =>
[16] =>
)
[page_count] => 16
[pdf_ping_data] => Array
(
[page_count] => 16
[format] => PDF
[width] => 765
[height] => 1080
[colorspace] => COLORSPACE_UNDEFINED
)
[linked_companies] => Array
(
[ids] => Array
(
)
)
[cover_url] =>
[cover_three] =>
[cover] => ![Implant Tribune U.S. No. 7, 2011]()
[toc] => Array
(
[0] => Array
(
[title] => JOI: Gene combination identified as risk factor in success of dental implants
[page] => 01
)
[1] => Array
(
[title] => ICOI returns to Chicago
[page] => 01
)
[2] => Array
(
[title] => Clinical and diagnostic advantages of PreXion 3-D imaging system
[page] => 01
)
[3] => Array
(
[title] => Industry
[page] => 11
)
)
[toc_html] =>
Table of contents
[toc_titles] => JOI: Gene combination identified as risk factor in success of dental implants
/ ICOI returns to Chicago
/ Clinical and diagnostic advantages of PreXion 3-D imaging system
/ Industry
[cached] => true
)